This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas Rea: Inventor in Cardiac Rhythm Prediction
Introduction
Thomas Rea is an inventor based in Seattle, Washington, and is associated with the University of Washington. His work includes an invention focused on predicting and treating refractory ventricular fibrillation, a heart rhythm that can resist standard defibrillation.
Latest Patents
Rea is associated with 1 patent, titled “Techniques for Predicting and Treating Refractory Ventricular Fibrillation.” The method analyzes electrocardiogram (ECG) segments recorded before and after an electrical shock. It converts the segments into scalograms and compares them with eigenscalograms to predict whether the ECG indicates a defibrillation-resistant rhythm. The method then outputs an indication of that prediction.
Career Highlights
Rea’s patent work addresses the use of ECG analysis to identify rhythms that may not respond to electrical shocks. The disclosed approach combines information from ECG data collected on both sides of a shock to support prediction.
Collaborations
The patent information names Jason Coult and Peter J. Kudenchuk among Rea’s coworkers. The work is associated with the University of Washington.
Conclusion
Thomas Rea’s patent describes an ECG-based approach to predicting refractory ventricular fibrillation, highlighting his contribution to innovation in cardiac rhythm analysis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile